Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

TNF-induced target cell killing by CTL activated through cross-presentation.

Wohlleber D, Kashkar H, Gärtner K, Frings MK, Odenthal M, Hegenbarth S, Börner C, Arnold B, Hämmerling G, Nieswandt B, van Rooijen N, Limmer A, Cederbrant K, Heikenwalder M, Pasparakis M, Protzer U, Dienes HP, Kurts C, Krönke M, Knolle PA.

Cell Rep. 2012 Sep 27;2(3):478-87. doi: 10.1016/j.celrep.2012.08.001. Epub 2012 Aug 30.

2.

Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.

Kafrouni MI, Brown GR, Thiele DL.

J Immunol. 2001 Aug 1;167(3):1566-74.

3.

Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro.

Smith CA, Woodruff LS, Kitchingman GR, Rooney CM.

J Virol. 1996 Oct;70(10):6733-40.

4.

Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.

Arancia G, Malorni W, Donelli G.

Ann Ist Super Sanita. 1990;26(3-4):369-84. Review.

PMID:
2151107
5.

Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo.

Yang Y, Wilson JM.

J Immunol. 1995 Sep 1;155(5):2564-70.

PMID:
7650386
6.

Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.

Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, Okumura K, Imawari M.

J Immunol. 1997 Jun 1;158(11):5283-91.

PMID:
9164947
7.

RPE cells resist bystander killing by CTLs, but are highly susceptible to antigen-dependent CTL killing.

Gregerson DS, Lew KL, McPherson SW, Heuss ND, Ferrington DA.

Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5385-94.

PMID:
17122128
9.

The role of TNF-TNFR2 interactions in generation of CTL responses and clearance of hepatic adenovirus infection.

Kafrouni MI, Brown GR, Thiele DL.

J Leukoc Biol. 2003 Oct;74(4):564-71. Epub 2003 Jul 15.

PMID:
12960267
10.

Fas-mediated apoptosis causes elimination of virus-specific cytotoxic T cells in the virus-infected liver.

Liu ZX, Govindarajan S, Okamoto S, Dennert G.

J Immunol. 2001 Mar 1;166(5):3035-41.

11.
12.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
14.

Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.

Jirmo AC, Nagel CH, Bohnen C, Sodeik B, Behrens GM.

J Immunol. 2009 Jan 1;182(1):283-92.

15.

Suppression of adenoviral gene expression in the liver: role of innate vs adaptive immunity and their cell lysis mechanisms.

Minagawa M, Kawamura H, Liu Z, Govindarajan S, Dennert G.

Liver Int. 2005 Jun;25(3):622-32.

PMID:
15910500
16.

Antiviral cytokines induce hepatic expression of the granzyme B inhibitors, proteinase inhibitor 9 and serine proteinase inhibitor 6.

Barrie MB, Stout HW, Abougergi MS, Miller BC, Thiele DL.

J Immunol. 2004 May 15;172(10):6453-9.

17.

Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.

van Mierlo GJ, Boonman ZF, Dumortier HM, den Boer AT, Fransen MF, Nouta J, van der Voort EI, Offringa R, Toes RE, Melief CJ.

J Immunol. 2004 Dec 1;173(11):6753-9.

18.

Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses.

Selin LK, Nahill SR, Welsh RM.

J Exp Med. 1994 Jun 1;179(6):1933-43.

Supplemental Content

Support Center